BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 26227811)

  • 1. Conditional inactivation of Akt three isoforms causes tau hyperphosphorylation in the brain.
    Wang L; Cheng S; Yin Z; Xu C; Lu S; Hou J; Yu T; Zhu X; Zou X; Peng Y; Xu Y; Yang Z; Chen G
    Mol Neurodegener; 2015 Jul; 10():33. PubMed ID: 26227811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroglobin attenuates Alzheimer-like tau hyperphosphorylation by activating Akt signaling.
    Chen LM; Xiong YS; Kong FL; Qu M; Wang Q; Chen XQ; Wang JZ; Zhu LQ
    J Neurochem; 2012 Jan; 120(1):157-64. PubMed ID: 21496024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation of tau at THR212 and SER214 in human neuronal and glial cultures: the role of AKT.
    Kyoung Pyo H; Lovati E; Pasinetti GM; Ksiezak-Reding H
    Neuroscience; 2004; 127(3):649-58. PubMed ID: 15283964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kainate induces AKT, ERK and cdk5/GSK3beta pathway deregulation, phosphorylates tau protein in mouse hippocampus.
    Crespo-Biel N; Canudas AM; Camins A; Pallàs M
    Neurochem Int; 2007 Jan; 50(2):435-42. PubMed ID: 17116346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redundant and Nonredundant Functions of Akt Isoforms in the Retina.
    Rajala RVS; Rajala A
    Adv Exp Med Biol; 2018; 1074():585-591. PubMed ID: 29721991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic inactivation of p62 leads to accumulation of hyperphosphorylated tau and neurodegeneration.
    Ramesh Babu J; Lamar Seibenhener M; Peng J; Strom AL; Kemppainen R; Cox N; Zhu H; Wooten MC; Diaz-Meco MT; Moscat J; Wooten MW
    J Neurochem; 2008 Jul; 106(1):107-20. PubMed ID: 18346206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isorhynchophylline treatment improves the amyloid-β-induced cognitive impairment in rats via inhibition of neuronal apoptosis and tau protein hyperphosphorylation.
    Xian YF; Mao QQ; Wu JC; Su ZR; Chen JN; Lai XP; Ip SP; Lin ZX
    J Alzheimers Dis; 2014; 39(2):331-46. PubMed ID: 24164737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology.
    Griffin RJ; Moloney A; Kelliher M; Johnston JA; Ravid R; Dockery P; O'Connor R; O'Neill C
    J Neurochem; 2005 Apr; 93(1):105-17. PubMed ID: 15773910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selenium treatment significantly inhibits tumor necrosis factor-α-induced cell death and tau hyperphosphorylation in neuroblastoma cells.
    Lee YJ; Kim JE; Kwak MH; Go J; Yang SY; Kwon HS; Kim BC; Kim JM; Hwang DY
    Mol Med Rep; 2014 Oct; 10(4):1869-74. PubMed ID: 25109896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin ameliorates amyloid beta-induced memory deficits, tau hyperphosphorylation and neurodegeneration via PI3/Akt/GSk3β pathway in the mouse hippocampus.
    Ali T; Kim MO
    J Pineal Res; 2015 Aug; 59(1):47-59. PubMed ID: 25858697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Escitalopram Ameliorates Forskolin-Induced Tau Hyperphosphorylation in HEK239/tau441 Cells.
    Ren QG; Wang YJ; Gong WG; Zhou QD; Xu L; Zhang ZJ
    J Mol Neurosci; 2015 Jun; 56(2):500-8. PubMed ID: 25687330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation of tau at Ser214 mediates its interaction with 14-3-3 protein: implications for the mechanism of tau aggregation.
    Sadik G; Tanaka T; Kato K; Yamamori H; Nessa BN; Morihara T; Takeda M
    J Neurochem; 2009 Jan; 108(1):33-43. PubMed ID: 19014373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal insulin ameliorates tau hyperphosphorylation in a rat model of type 2 diabetes.
    Yang Y; Ma D; Wang Y; Jiang T; Hu S; Zhang M; Yu X; Gong CX
    J Alzheimers Dis; 2013; 33(2):329-38. PubMed ID: 22936005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of microtubule-associated protein tau by isoforms of c-Jun N-terminal kinase (JNK).
    Yoshida H; Hastie CJ; McLauchlan H; Cohen P; Goedert M
    J Neurochem; 2004 Jul; 90(2):352-8. PubMed ID: 15228592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Akt Regulates Sox10 Expression to Control Oligodendrocyte Differentiation via Phosphorylating FoxO1.
    Wang H; Liu M; Ye Z; Zhou C; Bi H; Wang L; Zhang C; Fu H; Shen Y; Yang JJ; Hu Y; Chen G
    J Neurosci; 2021 Sep; 41(39):8163-8180. PubMed ID: 34385359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine D1 receptor activation induces tau phosphorylation via cdk5 and GSK3 signaling pathways.
    Lebel M; Patenaude C; Allyson J; Massicotte G; Cyr M
    Neuropharmacology; 2009 Sep; 57(4):392-402. PubMed ID: 19591849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro analysis of tau phosphorylation sites and its biological activity.
    Wang J; Wang X; Liu R; Wang Q; Grundke-Iqbal I; Iqbal K
    Chin Med Sci J; 2002 Mar; 17(1):13-6. PubMed ID: 12894878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of human tau protein by microtubule-associated kinases: GSK3beta and cdk5 are key participants.
    Flaherty DB; Soria JP; Tomasiewicz HG; Wood JG
    J Neurosci Res; 2000 Nov; 62(3):463-72. PubMed ID: 11054815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Akt and CHIP coregulate tau degradation through coordinated interactions.
    Dickey CA; Koren J; Zhang YJ; Xu YF; Jinwal UK; Birnbaum MJ; Monks B; Sun M; Cheng JQ; Patterson C; Bailey RM; Dunmore J; Soresh S; Leon C; Morgan D; Petrucelli L
    Proc Natl Acad Sci U S A; 2008 Mar; 105(9):3622-7. PubMed ID: 18292230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces Alzheimer disease-associated tau hyperphosphorylation in the hippocampus of rats with type 2 diabetes.
    Xu W; Yang Y; Yuan G; Zhu W; Ma D; Hu S
    J Investig Med; 2015 Feb; 63(2):267-72. PubMed ID: 25479064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.